Delivery Order SPE2DB22D1002-SPE2DB25FKYU6

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,188.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Orencia Clickject 125 mg/ml medication, with a firm fixed price and an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $11,144.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia Clickject 125 mg/ml, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,663.84, is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order with an ultimate completion date of October 31, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an...
This federal contract award, valued at $33,783.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of Orencia ClickJect 125 mg/mL, a specialty medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $22,341.90, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia Clickject 125 mg/mL, a specialty medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, valued at $15,817.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed price and an ultimate completion date of May 28, 2024, is for the delivery of Orencia Clickject 125 mg/ml, a specialty medication. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, valued at $15,687.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 5, 2024. The contract is for the procurement of Orencia Clickject 125 mg/ml, a medication used in the treatment of various medical conditions. This contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,379.80 firm fixed-price delivery order is for the supply of Orencia Clickject 125 mg/ml medication and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,004.75 firm fixed-price delivery order contract is to procure Orencia ClickJect 125 mg/mL medication for DLA Troop Support Medical. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award, valued at $55,062.28, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for Orencia ClickJect 125 mg/mL, a specialty medication. The contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKYU6
    Delivery Order

This federal contract award, valued at $7,188.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The award is for the supply of Orencia ClickJect 125 mg/mL, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. As a prime contractor, Amerisourcebergen Drug Corp will be responsible for delivering these medical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price arrangement, with a performance period extending through March 2025.

Generated 5/30/25, 9:42 AM